Andrew C. Haller, Ph.D.
Affiliations: | 2013 | Roswell Park . Pharmacology | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
Cell Biology, Molecular Biology, OncologyGoogle:
"Andrew Haller"Parents
Sign in to add mentor| Fengzhi Li | grad student | 2013 | SUNY Buffalo | |
| (The roles of the E26 transcription family member, SAM pointed domain-containing ETS transcription factor (SPDEF), in early stage prostate cancer and the development of castration recurrent disease.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Haller AC, Tan W, Payne-Ondracek R, et al. (2014) High SPDEF may identify patients who will have a prolonged response to androgen deprivation therapy. The Prostate. 74: 509-19 |
| Cheng Q, Ling X, Haller A, et al. (2012) Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoter. International Journal of Biochemistry and Molecular Biology. 3: 179-97 |
| Haller AC, Morrison C, Tan W, et al. (2012) Abstract 3637: Loss of prostate derived Ets (E-twenty six) transcription factor (PDEF) predicts patients at the highest risk of metastatic prostate cancer Cancer Research. 72: 3637-3637 |
| haller AC, Li F. (2012) Abstract 2871: Inhibition of androgen receptor-mediated expression of prostate derived ets transcription factor (PDEF) induces a loss of prostate cancer cell differentiation Cancer Research. 72: 2871-2871 |
| Haller AC, Morrison C, Payne-Ondracek R, et al. (2011) Abstract 4173: Prostate derived Ets (E-twenty six) transcription factor (PDEF) as a prognostic biomarker for metastatic prostate cancer Cancer Research. 71: 4173-4173 |